| Code | CSB-RA011583MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to reference antibody 9MW3811, designed to specifically target interleukin-11 (IL-11), a member of the IL-6 cytokine family. IL-11 is a pleiotropic cytokine that plays critical roles in cellular signaling, influencing fibroblast activation, extracellular matrix production, and inflammatory responses. Elevated IL-11 expression has been implicated in various pathological conditions, including tissue fibrosis affecting the heart, lung, liver, and kidney, as well as inflammatory disorders and certain cancers. The cytokine signals through a heterodimeric receptor complex involving IL-11 receptor alpha and gp130, activating downstream JAK-STAT and MAPK pathways.
The reference antibody 9MW3811 has been utilized in research investigating IL-11-mediated pathological processes, particularly in fibrotic disease models and cancer biology. This biosimilar provides researchers with a reliable tool for studying IL-11 biology, exploring its role in disease pathogenesis, and evaluating potential therapeutic interventions targeting IL-11 signaling pathways. The antibody is suitable for various investigative studies aimed at understanding the mechanisms underlying IL-11-driven pathologies.
There are currently no reviews for this product.